Y. G. Li

Prasugrel pharmacokinetics and pharmacodynamics in subjects with moderate renal impairment and end‐stage renal disease

K. Winters, R. Wrishko, J. Brandt, 2009, Journal of clinical pharmacy and therapeutics.

Pharmacokinetics and pharmacodynamics of prasugrel in subjects with moderate liver disease

K. Winters, C. Ernest, N. Farid, 2009, Journal of clinical pharmacy and therapeutics.

Prasugrel, a New Thienopyridine Antiplatelet Drug, Weakly Inhibits Cytochrome P450 2B6 in Humans

K. Winters, C. Ernest, N. Farid, 2008, Journal of clinical pharmacology.

Effect of rifampin on the pharmacokinetics and pharmacodynamics of prasugrel in healthy male subjects

K. Winters, C. Ernest, J. Jakubowski, 2009, Current medical research and opinion.